Pancreatic or duodenal neuroendocrine tumors are discovered when a related endocrine syndrome occurs, or during abdominal examination performed for surveillance of MEN1 patients and asymptomatic carriers of MEN1 gene mutation. The gene discussed is MEN1; the disease is duodenal neuroendocrine tumor, well differentiated, low or intermediate grade.